The Imaging Solutions business unit of Pembroke, Bermuda-based healthcare product and device developer Covidien showed an increase in sales for its fiscal 2007 third quarter (end-June 29). This was the firm’s first quarterly report following its separation from Tyco International on June 29 this year.
The firm said that Imaging Solutions sales rose 4.8 percent to $238 million, compared with $227 million in the prior year’s third quarter. Favorable foreign exchange contributed 2 percentage points to the sales growth rate, Covidien said.
Sales of radiopharmaceuticals were well above those of last year, due to higher sales of cardiology and oncology products, as well as increased generator volume, the firm said. The generator sales gain was aided by comparison to the year-ago period, when recall issues restrained sales, Covidien noted.
Sales of contrast agents and contrast delivery systems were about even with a year ago, the company reported. Growth in contrast delivery systems was countered by a small decline in sales of contrast agents, as higher contrast agent unit volume was more than offset by significant pricing declines in the quarter, according to Covidien.